BRAUN
Braun, the one-of-a-kind brand celebrating its 100 years in 2021, has entered a unique collaboration with the Chief Creative Officer and Founder of Off-White™ and Artistic Director of Louis Vuitton Menswear, Virgil Abloh. Today, the design leaders unveil their “functional art” piece with a film on www.Braun.com . A remix track by Virgil Abloh is also available on Abloh’s Soundcloud to bring the Braun ethos of good design to life: “it’s timeless and meant to be appreciated and enjoyed over time.”
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005718/en/
The collaboration with Virgil Abloh sees the designer delve into the Braun archives to update and co-curate the 1965 ‘Wandanlage’ hi fi audio wall unit with Braun’s design team into a “functional art” piece. The metallic finish of the 2021 version is a visual manifestation of the parallels between Braun’s polished chrome design aesthetic – such as the 1960 SM3 shaver and 1961 T1 toaster - and the high shine of Virgil Abloh’s cultural and musical references of the past 100 years. These range from the brass and silver instruments of Mamie Smith’s 1930s blues band to the customized polished ‘slabs’ on cars made famous by hip hop stars in the 1980s. By taking a ‘less but better’ approach to the design process, Virgil Abloh and Braun ensure that the original hi fi audio remains the hero of the collaboration – and the technology still functions today as it did back in 1965. The result is a custom build “functional art” piece where design bridges the gap between form and function, with materials that ensure it lasts for the next 100 years.
Virgil Abloh said: “I have always had a deep appreciation for Braun design. For the brand’s 100 years, I jumped at the opportunity to reimagine this iconic Braun product and challenge what we have come to expect from design. The “functional art” piece co-curated with Braun Design not only highlights the original function of the hi fi wall unit that was the best audio of its time, but also the quality and durable materials that are built to last. As a creator, I continue to question how art is perceived in today’s culture. “Functional art” is a lasting legacy of the enduring power of good design that is simple, useful and built to last. In so doing, it advances the frames of design references beyond design ‘purists’ to broader audiences.”
The short film follows Abloh at Farnsworth House – designed and constructed by Ludwig Mies van der Rohe – as he explains his design process behind the reimagined Wandanlage. In a nod to his practice as a DJ, Virgil Abloh has also curated a bespoke remix composition titled ‘Internationalism’ so design ‘purists’ and broader audiences can experience the musical inspiration behind the collaboration.
Virgil said: “The track was conceived in collaboration with The Chopstars, the epochal Houston sound designers; the net result being chopped and screwed jazz classics. The track itself is an audio expression of the thesis in which parallels can be drawn in reference to The Chopstar process, as it relates to the development of our collaboration’s “Functional Art.” The hallmark of the work is rooting the industrial design and existence of the Canon to embody Black culture in a specific way that Houston brand of music specifically achieves - the Chopped not Slopped sonic texture picks up where design leaves off.”
The eclectic track embodies a ‘genre-less’ approach to music, something that Virgil has spoken about before in reference to his musical taste, commenting: “Eclectic, genre-less, longevity, connection, using sound to paint pictures. I always have music on in the background of everything I do. My musical tastes know no boundaries; they don’t fit within a box or a category, very much so in the same way that I or my work don’t just sit in one space. “Internationalism” is a diverse and varied track, yet cohesive in its sentiment. To me, this track exemplifies the Braun ethos of good design – it’s timeless and meant to be appreciated and enjoyed over time.”
To watch the film and find out more information on the Virgil Abloh x Braun collaboration to mark Braun’s 100 years of ‘good design’, please visit www.Braun.com
.
The music track ‘Internationalism’ is available at https://soundcloud.com/vvvirgilabloh
.
- ENDS -
Note to editors:
Braun, a subsidiary of Procter & Gamble founded in Germany in 1921, develops and manufactures a wide variety of small domestic appliances that marry technical innovation, reliable quality and distinctive design. These range from electric shavers and beauty products to hair care appliances. Braun products enjoy worldwide distribution. Please visit www.braun.com for the latest news and in-depth information about the Braun brand.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005718/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sodali & Co Announces Executive Leadership Appointments7.1.2026 17:00:00 CET | Press release
Accelerates Firm Strategy to Deliver Global Integrated Stakeholder Solutions Sodali & Co (the ‘firm’ or ‘Sodali’), the leading global capital markets-centric stakeholder advisory firm, is pleased to announce four appointments to its Executive Leadership Team (ELT) under Chief Executive Officer Andrew Benett. These newly created senior roles will strengthen Sodali’s ability to respond to clients’ evolving needs with an integrated suite of shareholder, sustainability, and strategic communications advisory services delivered on a global scale. The appointments are as follows: Brett Clegg has been promoted to Chief Commercial Officer. Brett was previously Chairman of Sodali’s APAC region, based in the firm’s Sydney office. He specializes in advising clients on strategic communications, issues management, and capital markets transactions. Prior to Sodali, Brett spent over two decades in senior executive and editorial roles at some of Australia’s leading news brands, including The Australian
1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 14:15:00 CET | Press release
In 2025 1NCE added another 10 million endpoints to its foundational IoT platform; now manages 40+ million intelligent products for 30,000 customers in 17 industries. Introduces new software, 1NCE Insights, the AI + IoT fusion of intelligence from its network that gives analytics and benchmark data on how customers can better setup, manage and optimize their device estates. 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 14:00:00 CET | Press release
Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
